Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotech VC (Venture Capital) Funds in Austria in May 2025

Last updated: May 2025 A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Austria. We rank investors based on the number of investments they made in Biotech companies from Austria. We update this investor list every month.

Top 50 Biotech VC (Venture Capital) Funds in Austria in May 2025

Investor	Biotech Austria investments
xista science ventures	10
xista science ventures	9
tecnet equity	6
austria Wirtschaftsservice (aws)	5
SOSV	5
MIG Capital	5
Arax Capital Partners	3
BackBone Ventures	2
The Austrian Research Promotion Agency (FFG)	2
Übermorgen Ventures	2
red-stars.com	2
FPS-Holding	2
APEX Ventures	2
bmp Ventures	2
aws Gründungsfonds	2
Aescap Venture	2
Longevitytech.fund	2
R42 Group	2
PUSH VC	2
Lansdowne Partners	2
10x Founders	2
TSVC	2
APEX Ventures	2
Nina Capital	2
HCVC	1
Credit Agricole CIB	1
Gamma Capital Partners	1
ReGen Ventures	1
Novartis Venture Fund	1
HBM Partners	1
IPO Beteiligungs-Management	1
Polaris Partners	1
Andera Partners	1
Tet Ventures	1
4SC	1
Sofinnova Partners	1
PONTIS Venture Partners Management	1
Possible Ventures	1
Ligand Pharmaceuticals	1
Borregaard ASA	1
Climentum Capital	1
Pace Ventures	1
42CAP	1
RKP InnoInvest	1
Kale United	1
FastVentures	1
OrbiMed	1
HackCapital	1
Die Wirtschaftskammer	1
IBG Beteiligungsgesellschaft Sachsen-Anhalt	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Investment focus

Biotechnology, Medical, Medical Device
Seed, Pre-Seed, Series A
Austria, France, Slovenia

Portfolio highlights

Syntropic Medical GmbH — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.

Investment focus

Biotechnology, Medical, Software
Seed, Pre-Seed, Series A
Austria, Slovenia

Portfolio highlights

subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Investment focus

Software, SaaS, Information Technology
Seed, Funding Round, Series A
Austria

Portfolio highlights

Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Investment focus

Software, Information Technology, SaaS
Seed, Grant, Pre-Seed
Austria, Belgium

Portfolio highlights

HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
Aileen Health — Next frame predictions for medical images.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Zusammen gestalten wir die Unternehmen von morgen.

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
Germany, France, Austria

Portfolio highlights

Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round
Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
Calyxha Biotechnologies GmbH — A new perspective on inflammation

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Investment focus

Information Technology, Artificial Intelligence, Software
Seed, Pre-Seed, Funding Round
Switzerland, Germany, Israel

Portfolio highlights

Syn2core — We are a startup in stealth mode, working on an AI co-pilot to empower frontline workers in automotive.
Cloudsquid — is an an artificial intelligence based revenue orchestration company intended for companies with usage-based pricing models.
CROWN — Drive savings and supplier competition with CROWN's eAuction service. Smart reverse auctions built for procurement teams. Book your free demo today.

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Investment focus

Software, Artificial Intelligence, Health Care
Grant, Seed, Pre-Seed
Austria, United States, Belgium

Portfolio highlights

Synaps — The collaborative architectural platform where you can draw plans, delegate tasks and gather real-time feedback, all in one place. Join the waitlist.
SOMAREALITY — SOMAREALITY provides eye tracking solutions for diverse industries. Improve healthcare, automotive, research & aviation with real-time cognitive insights.
Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival

We are an early stage VC for climate tech startups.

Investment focus

Software, Energy, Renewable Energy
Seed, Pre-Seed, Funding Round
Germany, Switzerland, Finland

Portfolio highlights

Green Fusion — Green Fusion is developing a cloud-based energy manager for the intelligent control of heat, electricity, and e-mobility. The focus here is on hybrid heating systems in buildings such as heat pumps + gas boilers and the coupling to photovoltaic systems and electric vehicle charging stations.
Marathon Fusion — The fuel cycle for fusion energy.
Open Forest Protocol — With Open Forest Protocol (OFP), measure, report, verify and fund forestation projects with digital transparency

red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.

Investment focus

Software, Biotechnology, Telecommunications
Funding Round, Seed
Austria, Germany

Portfolio highlights

Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.

SPV

Investment focus

Biotechnology, Health Diagnostics
Seed
Austria

Portfolio highlights

Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.

APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Investment focus

Information Technology, Software, Manufacturing
Seed, Funding Round, Series A
Germany, United States, Austria

Portfolio highlights

Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
XenoPatch GmbH — First-ever portable device for pain management, seamlessly combines heat, cold and vibration treatment with an intuitive smartphone app.

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
Austria, United States, Germany

Portfolio highlights

Tree.ly — Tree.ly does climate protection through the projects in European forests through its SaaS platform and hyperlocal CO2-credits.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

Investment focus

Biotechnology, Pharmaceutical, Chemical
Series A, Series B, Funding Round
United Kingdom, Austria, Belgium

Portfolio highlights

Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja JÃ¤Ã¤ttela and Thomas Kirkegaard Jensen from the Danish Cancer Society (KrÃ¦ftens BekÃ¦mpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.

Investing globally in technologies extending healthy lifespans

Investment focus

Biotechnology, Health Care, Personal Health
Seed, Convertible Note, Pre-Seed
United States, United Kingdom, The Netherlands

Portfolio highlights

Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Funding Round, Pre-Seed
United Kingdom, United States, Austria

Portfolio highlights

Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.

| Investments that move industries

Investment focus

Software, Apps, Information Technology
Seed, Series A, Funding Round
Austria, Germany, United States

Portfolio highlights

Podero — Podero's aim is to create software that controls energy devices, such as batteries, electric cars, and heat pumps, in order to lower CO2 emissions, create new revenue streams for utilities, and lower consumer electricity bills.Podero's objective is to make it possible to coordinate the largest fleet of devices in the world by utilizingtrade algorithms, software automation, and machine learning forecasts to move energy use to the most economical and sustainable times.
enspired — enspired is a fully digital energy trading-as-a-service company. We drive the energy transition by enabling our clients to bring flexible assets to power spot markets and capture their full value with our AI-based trading services. Our team consists of leading algorithmic traders, data scientists and technology enthusiasts who firmly believe thatthe way power is traded will soon drastically change - in our world, there is no room for trading screens and traditional optimization. All trades get executed in a fully automated fashion using advanced AI algorithms that outperform the market and monetize our client's flexibility to the fullest while supporting grid stability. Our clients include leading utilities, operators of renewables and batteries or consumption assets across Europe.
UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.

Fundamental Equity Investing, since 1998

Investment focus

Biotechnology, Machine Learning, Finance
Funding Round, Series A, Series B
United Kingdom, Austria, United States

Portfolio highlights

Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
AMNIS Treasury Services — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
Landeed — Do you own your land? Download Landeed app to check real ownership of your property
qeen.ai — qeen.ai is a GenAI native platform that enables autonomous AI to e-commerce firms of all sizes.

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Funding Round, Series A
United States, China, Canada

Portfolio highlights

Akool — Akool provides a generative AI platform that supercharges business with personalized premium quality visual content for marketing and advertisement.
Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
Place Genomics Corporation — Bio Tech

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Medical
Seed, Pre-Seed, Series A
United States, United Kingdom, Germany

Portfolio highlights

CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
Sonar — Sonar is a scalable mental health platform for schools. We use a combination of AI and human connection to ensure every student is seen and supported. For educators, Sonar offers actionable insights to improve mental wellbeing, empower your staff, and boost student outcomes.
MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.

HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.

Investment focus

Software, Robotics, Artificial Intelligence
Seed, Series A, Pre-Seed
United States, France, United Kingdom

Portfolio highlights

Karman+ — Mining near Earth asteroids
Alpine Eagle — The Sentinel Counter-UAS System is an air-to-air sensor & interceptor network designed to detect, classify, and intercept unmanned aerial systems (UAS)
Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.

Crédit Agricole CIB specialises in the businesses of capital markets and investment and corporate banking.

Investment focus

Energy, Biotechnology, Health Care
Debt Financing, Series A, Series B
France, United Kingdom, United States

Portfolio highlights

ShowYou — They are developing the first digital solution dedicated to real estate developers for the management of acquisition modifying works (TMA). They created the first configurator in interactive plans allowing the customer to study his own modifications under the control of the promoter. With SHOW YOU: - save time - clarify and make the work morereliable - improve the satisfaction of your customers
Credem Banca — Credem Banca provides banking services.
Gunvor Group — Gunvor Group is one of the world’s largest independent commodities trading houses by turnover, creating logistics solutions that safely and efficiently move physical energy from where it is sourced and stored to where it is demanded most. With strategic investments in industrial infrastructure—refineries, pipelines, storage, terminals, mining andupstream—Gunvor further generates sustainable value across the global supply chain for its customers.

GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm established in 2002 (GCP Presentation 2020). We focus on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria. We aim for value creation and value realization to generate superior returns for our investors and clients.

Investment focus

Mobile, iOS, Mobile Apps
Series A, Seed, Series C
Austria, Switzerland, United States

Portfolio highlights

Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.

Investing in the ReGeneration

Investment focus

Agriculture, Biotechnology, Farming
Seed, Series A, Series B
United States, Austria, United Kingdom

Portfolio highlights

Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
PACT — PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals.
Ulysses Ecosystem Engineering — Ulysses rewild the ocean and remove gigatons of carbon, contributing to global efforts to combat climate change and restore marine ecosystems.

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Investment focus

Biotechnology, Medical, Health Care
Series B, Funding Round, Series C
United States, Germany, Switzerland

Portfolio highlights

Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.

IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.

Investment focus

Sensor, Medical, Wireless
Series B, Funding Round
Austria

Portfolio highlights

SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
United States, Singapore, Ireland

Portfolio highlights

Tausight — Tausight is specifically designed to help Healthcare ensure the confidentiality, integrity, and availability of ePHI.
Triveni Bio — Triveni Bio is pioneering a genetics-informed precision medicine approach to develop functional antibodies to treat immunological and inflammatory disorders.
Engine Biosciences — We digitize and decipher complex biology with cutting-edge technologies to discover and develop life-changing medicines.

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Investment focus

Biotechnology, Health Care, Medical
Series B, Private Equity, Funding Round
France, United States, Germany

Portfolio highlights

MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Tet Ventures is one of the most active global food-tech investors. We work with and invest in technology that can improve the food system.

Investment focus

Food and Beverage, Biotechnology, E-Commerce
Seed, Pre-Seed, Funding Round
United States, Germany, United Kingdom

Portfolio highlights

Afterlife Ag — Eliminate organic waste from going into landfills. Peat upcycles your food waste into fresh, sustainable, and delicious mushrooms.
FORAY bioscience — FORAY bioscience is a biotechnology company that uses biomanufacturing techniques to produce wood products.
Prolific Machines — Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Investment focus

Health Care, Biotechnology
Seed
Austria

Portfolio highlights

Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

BetterOmics — The Omics AI Cloud
l`école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.

PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Series C
Austria, Germany

Portfolio highlights

evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Investment focus

Software, Information Technology, Biotechnology
Seed, Pre-Seed, Series A
Germany, Australia, United States

Portfolio highlights

Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.

A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Investment focus

Health Care, Biotechnology, Medical
Corporate Round, Post-IPO Debt, Series A
United States, Austria

Portfolio highlights

Agenus — Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients
invIOs — invIOs is a private biotechnology company that specializes in the discovery and development of next-generation cancer therapies that empower and educate the immune system to fight cancer.
Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options

Borregaard operates one of the world's most advanced and sustainable biorefineries.

Investment focus

Biotechnology, Chemical Engineering
Seed
Austria

Portfolio highlights

Kaffe Bueno — Kaffe Bueno upcycles coffee waste into active and functional ingredients for cosmetics, nutraceuticals and functional foods.
Alginor ASA — Alginor ASA is a marine biotech company committed to total utilisation of kelp through novel methods, making more than just alginates.
Lignovations — Lignovations develops high-performance ingredients from biomass. Accelerating the transition to a sustainable society.

A Venture Capital firm investing into European early-stage tech companies attacking CO2 emissions

Investment focus

CleanTech, Clean Energy, Biotechnology
Seed, Series A, Series B
Sweden, Spain, Austria

Portfolio highlights

ecoLocked — ecoLocked is your partner to create a climate-positive built environment. We develop CO2-optimized recipes for concrete based on carbon-negative biochar admixes. Our admixes allow to store captured CO2 in buildings, reduce direct emissions from concrete production, and provide multiple functional benefits, such as improved thermal insulation.
Scale Energy — Reduce your energy cost without any investment
ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.

Investing at the intersection of climate and health.

Investment focus

Software, Biotechnology, Information Technology
Seed, Funding Round, Pre-Seed
United States, Germany, Austria

Portfolio highlights

Turnover Labs — Turnover Labs strives to decarbonize the chemical production business and transform how the world generates petrochemicals.
Vema Hydrogen — Vema Hydrogen is a pioneering clean hydrogen production company. It helps to fight the enormous decarbonization issue.
Dunia Innovation — Catalysing the energy transition.

We are peers amongst entrepreneurs helping the brave to build game-changing companies, just like we have done ourselves.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Series A, Series B
Germany, France, Sweden

Portfolio highlights

Codesphere — Codesphere is your Zeroconfig Cloud. No config - just code and run web apps from your browser. Team work on distributed full stack Typescript, and benefit from our automatic deployments, scaling, tests, and security / privacy audits. We optimize each and every detail to keep things simple for you. Codesphere is next level programming.
cognee inc — cognee helps you create a GraphRAG and supports Vector Stores, Graph stores, and various LLM providers
simplyblock — High-performance storage software designed for databases with low latency, high scalability and high IOPS. NVMe-optimized. Alternative SAN or EBS. Scalable Block Storage software. Simplyblock | Simply Block | Simplyblock Block Storage

RKP InnoInvest provides Investment capital and strategic services support progressive and dynamic start-ups and companies.

Investment focus

Biotechnology, Food and Beverage
Seed
Austria

Portfolio highlights

Hakuma — Hakuma is the full load of Matcha to which mango, lemon, ginger, agave and Baobab join.
Econutri — Recycling CO2 for sustainable protein production

Kale United offers a portfolio of over 75+ plant-based game changers

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Pre-Seed, Funding Round
United Kingdom, Sweden, India

Portfolio highlights

Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
The Pack — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."

venture capital

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Series B
Hungary, South Korea, United States

Portfolio highlights

Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

Aerin Medical — Aerin Medical offers VivAer for nasal airway obstruction treatment and RhinAer for chronic runny nose treatment. Lasting relief when other solutions fall short.
Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
Helicore Biopharma — Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders.

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

Investment focus

Biotechnology, Food and Beverage, Food Processing
Seed, Pre-Seed, Series A
United States, Israel, United Kingdom

Portfolio highlights

twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
UNCAGED Innovations — What if we could make leather without the animal? We are a biomaterials company combining the power of nature and technology to reimagine leather.

The Austrian Federal Economic Chamber functions as the federal parent organization for the nine State Chambers and 110 trade associations for different industries within Austria's system of economy.

Investment focus

Software, Music, mHealth
Seed, Pre-Seed, Funding Round
Austria

Portfolio highlights

Music Traveler — Music Traveler is a rapidly growing aggregator and marketplace, bringing a highly fragmented B2B and B2BC environment to the sharing economy. Music Traveler centralises practice/rehearsal/performing spaces, equipment, and instruction for the performing arts – its mission is to promote the creation, appreciation and interest in music byy reducing barriers, facilitating new interactions.
The Apollinaire Group (TAG) — Intelligent supply chain management company.
SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.

Investment focus

Electronics, Software, Medical Device
Funding Round, Seed, Series A
Germany, Austria

Portfolio highlights

Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.

Investors by industry

Artificial intelligence